SANUWAVE Health, Inc. Impairment of Intangible Assets, Finite-lived
SANUWAVE Health, Inc. (SNWV) reported Impairment of Intangible Assets, Finite-lived of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-05-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsFinitelived · last filed 2022-05-13
- SANUWAVE Health, Inc. impairment of intangible assets, finite-lived for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- SANUWAVE Health, Inc. impairment of intangible assets, finite-lived for fiscal 2020 was $7.18M.
- SANUWAVE Health, Inc. impairment of intangible assets, finite-lived for fiscal 2019 was $0.00.
| Period end | Impairment of Intangible Assets, Finite-lived 12 month | Impairment of Intangible Assets, Finite-lived 12 month as first filed |
|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-05-13 | |
| 2020-12-31 | $7.18M 10-K · filed 2022-05-13 | $7.19M 10-K · filed 2021-10-21 |
| 2019-12-31 | $0.00 10-K · filed 2021-10-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |